| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
2
5
2
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 7.23 | 1.06 | 6.16 |
| Stocks | 0.96 | 0.0 | 0.96 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.18 | 0.0 | 0.18 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 92.07 | 0.0 | 92.07 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.62 | 0.0 | 0.62 |
Updated 02.28.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 02.28.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| GMO US Treasury | --- | --- | 2.58 |
| Nihon Kohden Corporation | 6849 | --- | 1.71 |
| COSMOS Pharmaceutical Corporation | 3349 | --- | 1.54 |
| Primary Health Care Limited | PRY | --- | 1.4 |
| Asciano Limited | AANOF | 203.25 | 1.23 |
| Virbac | VRBCF | --- | 1.22 |
| Autogrill | AGL | --- | 1.21 |
| Prosafe SE | PRS | --- | 1.19 |
| Euromoney Institutional Investor PLC | ERM | --- | 1.14 |
| Filtrona PLC | FLRAF | 21.76 | 1.1 |
